Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Hsd17b14 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of HSD17B14 mRNA | CTD | PMID:22206623 | Hsd17b14 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of HSD17B14 mRNA | CTD | PMID:30723492 | Hsd17b14 | Rat | 17beta-estradiol | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of HSD17B14 mRNA | CTD | PMID:21185374 | Hsd17b14 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B14 mRNA | CTD | PMID:21570461 | Hsd17b14 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of HSD17B14 mRNA | CTD | PMID:28973697 | Hsd17b14 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Decitabine affects the expression of HSD17B14 mRNA | CTD | PMID:23300844 | Hsd17b14 | Rat | 8-Br-cAMP | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD17B14 mRNA | CTD | PMID:22079614 | Hsd17b14 | Rat | aflatoxin B1 | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of HSD17B14 mRNA | CTD | PMID:27153756 | Hsd17b14 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | HSD17B14 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of HSD17B14 intron | CTD | PMID:30157460 | Hsd17b14 | Rat | allopurinol | decreases expression | EXP | | 6480464 | Allopurinol results in decreased expression of HSD17B14 mRNA | CTD | PMID:37876353 | Hsd17b14 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of HSD17B14 mRNA | CTD | PMID:35163327 | Hsd17b14 | Rat | antirheumatic drug | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of HSD17B14 mRNA | CTD | PMID:24449571 | Hsd17b14 | Rat | aristolochic acid A | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of HSD17B14 mRNA | CTD | PMID:33212167 | Hsd17b14 | Rat | avobenzone | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | avobenzone results in increased expression of HSD17B14 mRNA | CTD | PMID:31016361 | Hsd17b14 | Rat | benzo[a]pyrene | decreases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of HSD17B14 mRNA | CTD | PMID:23735875 | Hsd17b14 | Rat | benzo[a]pyrene | affects methylation | ISO | HSD17B14 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of HSD17B14 5' UTR; Benzo(a)pyrene affects the methylation of HSD17B14 intron | CTD | PMID:27901495|PMID:30157460 | Hsd17b14 | Rat | benzo[a]pyrene | increases methylation | ISO | Hsd17b14 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of HSD17B14 exon; Benzo(a)pyrene results in increased methylation of HSD17B14 more ... | CTD | PMID:27901495 | Hsd17b14 | Rat | benzo[e]pyrene | increases methylation | ISO | HSD17B14 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of HSD17B14 intron | CTD | PMID:30157460 | Hsd17b14 | Rat | bisphenol A | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of HSD17B14 mRNA | CTD | PMID:19371625 | Hsd17b14 | Rat | bisphenol A | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of HSD17B14 mRNA; bisphenol A results in increased expression more ... | CTD | PMID:27685785|PMID:29275510 | Hsd17b14 | Rat | cadmium dichloride | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of HSD17B14 mRNA | CTD | PMID:38568856 | Hsd17b14 | Rat | chlorpyrifos | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of HSD17B14 mRNA | CTD | PMID:37019170 | Hsd17b14 | Rat | chrysene | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | chrysene results in increased expression of HSD17B14 mRNA | CTD | PMID:26377693 | Hsd17b14 | Rat | cisplatin | affects expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Cisplatin affects the expression of HSD17B14 mRNA | CTD | PMID:23300844 | Hsd17b14 | Rat | cisplatin | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of HSD17B14 mRNA | CTD | PMID:27392435 | Hsd17b14 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of HSD17B14 mRNA | CTD | PMID:26033743 | Hsd17b14 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of HSD17B14 mRNA | CTD | PMID:26033743 | Hsd17b14 | Rat | epoxiconazole | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of HSD17B14 mRNA | CTD | PMID:35436446 | Hsd17b14 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of HSD17B14 mRNA | CTD | PMID:30307764 | Hsd17b14 | Rat | fipronil | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [fipronil co-treated with DEET] results in increased expression of HSD17B14 mRNA | CTD | PMID:27091632 | Hsd17b14 | Rat | fipronil | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | fipronil results in increased expression of HSD17B14 mRNA | CTD | PMID:27091632 | Hsd17b14 | Rat | fluoxetine | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Fluoxetine results in increased expression of HSD17B14 mRNA | CTD | PMID:37386098 | Hsd17b14 | Rat | genistein | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Genistein results in decreased expression of HSD17B14 mRNA | CTD | PMID:19371625 | Hsd17b14 | Rat | hydrogen peroxide | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HSD17B14 protein | CTD | PMID:18951874 | Hsd17b14 | Rat | methapyrilene | increases methylation | ISO | HSD17B14 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of HSD17B14 intron | CTD | PMID:30157460 | Hsd17b14 | Rat | Moniliformin | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | moniliformin results in increased expression of HSD17B14 mRNA | CTD | PMID:39984025 | Hsd17b14 | Rat | N,N-diethyl-m-toluamide | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [fipronil co-treated with DEET] results in increased expression of HSD17B14 mRNA | CTD | PMID:27091632 | Hsd17b14 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of HSD17B14 mRNA | CTD | PMID:24810058 | Hsd17b14 | Rat | NAD zwitterion | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | NAD binds to and results in increased activity of HSD17B14 protein | CTD | PMID:25526675 | Hsd17b14 | Rat | NAD(+) | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | NAD binds to and results in increased activity of HSD17B14 protein | CTD | PMID:25526675 | Hsd17b14 | Rat | niclosamide | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of HSD17B14 mRNA | CTD | PMID:36318118 | Hsd17b14 | Rat | nitrates | multiple interactions | ISO | Hsd17b14 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HSD17B14 more ... | CTD | PMID:35964746 | Hsd17b14 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of HSD17B14 protein | CTD | PMID:26178269 | Hsd17b14 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of HSD17B14 mRNA | CTD | PMID:35163327 | Hsd17b14 | Rat | rotenone | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Rotenone results in increased expression of HSD17B14 mRNA | CTD | PMID:29955902 | Hsd17b14 | Rat | silicon dioxide | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of HSD17B14 mRNA | CTD | PMID:25895662 | Hsd17b14 | Rat | silver atom | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Silver results in increased expression of HSD17B14 mRNA | CTD | PMID:27131904 | Hsd17b14 | Rat | silver(0) | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Silver results in increased expression of HSD17B14 mRNA | CTD | PMID:27131904 | Hsd17b14 | Rat | sodium arsenite | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of HSD17B14 mRNA | CTD | PMID:38568856 | Hsd17b14 | Rat | sotorasib | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HSD17B14 mRNA | CTD | PMID:36139627 | Hsd17b14 | Rat | sunitinib | increases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of HSD17B14 mRNA | CTD | PMID:31533062 | Hsd17b14 | Rat | temozolomide | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of HSD17B14 mRNA | CTD | PMID:31758290 | Hsd17b14 | Rat | theophylline | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HSD17B14 protein | CTD | PMID:18951874 | Hsd17b14 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of HSD17B14 mRNA | CTD | PMID:34492290 | Hsd17b14 | Rat | trametinib | multiple interactions | ISO | HSD17B14 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HSD17B14 mRNA | CTD | PMID:36139627 | Hsd17b14 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of HSD17B14 mRNA | CTD | PMID:33387578 | Hsd17b14 | Rat | trichostatin A | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of HSD17B14 mRNA | CTD | PMID:24935251 | Hsd17b14 | Rat | valproic acid | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of HSD17B14 mRNA | CTD | PMID:24935251|PMID:28001369 | Hsd17b14 | Rat | vancomycin | increases expression | ISO | Hsd17b14 (Mus musculus) | 6480464 | Vancomycin results in increased expression of HSD17B14 mRNA | CTD | PMID:18930951 | Hsd17b14 | Rat | zearalenone | decreases expression | ISO | HSD17B14 (Homo sapiens) | 6480464 | Zearalenone results in decreased expression of HSD17B14 mRNA | CTD | PMID:19371625 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















